具有扩张周围血管作用的药物,又称周围血管扩张药(peripheral vasodilators)。至今,临床使用的此类药物种类繁多,大致可分为两大类。
第一类是直接松弛血管平滑肌的药物,即直接血管扩张药,如肼苯哒嗪、硝普钠和硝酸酯类。另一类则是通过不同的作用机制最终导致血管扩张的药物,包括α-肾上腺素受体阻断药、钙拮抗剂以及血管紧张素转化酶抑制剂。
这些药物不仅传统上用于治疗高血压等多种心血管疾病,还常被应用于急性和慢性心功能不全。其主要原理在于:这类药物能够扩张小静脉,减少回心血量,从而降低心室充盈压,减轻心脏前负荷;同时,它们还能扩张小动脉,减弱外周血管阻力,降低心室射血阻抗,进而减轻心脏后负荷。
由于这些有益的作用,心肌梗塞、高血压性心脏病或心脏直视手术后的急性左心衰竭和肺水肿患者,在使用血管扩张剂治疗时往往能获得显著疗效。尤其对慢性充血性心力衰竭而言,特别在洋地黄中毒或用洋地黄与利尿剂治疗无效的顽固性病例中,也能发挥相当的缓解作用。
临床实践证明,当应用适宜剂量时,这类药物能使动脉血压保持不变或轻度降低,并且不会引起显著的心率变化。然而,过大的剂量则可能导致严重低血压,因此在使用过程中应从小剂量开始并密切监护心率和血压;有条件的情况下,还可以监测肺毛细血管楔嵌压。
值得注意的是,长期应用此类药物时不应立即停药,以免引发反跳现象。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
阿魏酸钠 | 24276-84-4 | C10H10NaO4 |
|
|
长春西汀杂质N | (+/-)-Vincamin | 1617-90-9 | C21H26N2O3 |
|
长春西汀杂质1 | (+/-)-3-epi-apovincaminic acid ethyl ester | 42971-09-5 | C22H26N2O2 |
|
长春西汀 | Vinpocetine | 42971-09-5 | C22H26N2O2 |
|
长春胺 | vincamin | 1617-90-9 | C21H26N2O3 |
|
酚苄明 | phenoxybenzamine | 59-96-1 | C18H22ClNO |
|
酚妥拉明 | phentolamine | 50-60-2 | C17H19N3O |
|
萘呋胺酯 草酸盐 | Gevatran | 3200-06-4 | C2H2O4*C24H33NO3 |
|
萘呋胺酯 | nafronyl | 31329-57-4 | C24H33NO3 |
|
脑清 | nylidrin | 447-41-6 | C19H25NO2 |
|
羟苯磺酸钙 | 20123-80-2 | C6H6CaO5S |
|
|
盐酸酚苄明 | phenoxybenzamine hydrochloride | 63-92-3 | C18H22ClNO*ClH |
|
盐酸酚妥拉明 | phentolamine hydrochloride | 73-05-2 | C17H19N3O*ClH |
|
盐酸罂粟碱 | papaverine hydrochloride | 61-25-6 | C20H22NO4*Cl |
|
盐酸托哌酮 | Tolperisone hydrochloride | 3644-61-9 | C16H23NO*ClH |
|
盐酸妥拉唑林 | tolazoline hydrochloride | 59-97-2 | C10H12N2*ClH |
|
甲磺酸酚妥拉明 | phentolamine mesylate | 65-28-1 | CH4O3S*C17H19N3O |
|
甲磺酸倍他司汀 | betahistine methanesulphonate | 54856-23-4 | CH4O3S*C8H12N2 |
|
甲磺酸二氢麦角胺 | dihydroergotamine mesylate | 6190-39-2 | CH4O3S*C33H37N5O5 |
|
环扁桃酯 | cyclandelate | 456-59-7 | C17H24O3 |
|
烟酸占替诺 | xanthinol nicotinate | 437-74-1 | C6H5NO2*C13H21N5O4 |
|
氟桂利嗪 | flunarizine | 52468-60-7 | C26H26F2N2 |
|
桂利嗪 | cinnarizine | 298-57-7 | C26H28N2 |
|
托哌酮 | tolperisone | 728-88-1 | C16H23NO |
|
己酮可可碱 | pentoxyphylline | 6493-05-6 | C13H18N4O3 |
|
尼麦角林 | nicergoline | 27848-84-6 | C24H26BrN3O3 |
|
卡维地洛 | carvedilol | 72956-09-3 | C24H26N2O4 |
|
丙帕硝酯 | propatylnitrate | 2921-92-8 | C6H11N3O9 |
|
2-苯甲基咪唑啉 | tolazoline | 59-98-3 | C10H12N2 |
|
2-(2-甲基氨基乙基)吡啶 | betahistine | 5638-76-6 | C8H12N2 |
|
(aS,2R)-四氢-a-(1-萘甲基)-2-呋喃丙酸 2-(二乙基氨基)乙酯 | (2RS,2'SR)-2-(diethylamino)ethyl 2-<(naphth-1-yl)methyl>-3-(tetrahydrofuran-2-yl)propanoate | 31329-57-4 | C24H33NO3 |
|
—— | sodium 4-hydroxy-3-methoxycinnamate | 24276-84-4 | C10H9O4*Na |
|
—— | flunarizine hydrochloride | 30484-77-6 | C26H26F2N2*ClH |
|
—— | Betahistine mesilate | 54856-23-4 | C10H20N2O6S2 |
|
—— | N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-7-ium-9-carboxamide;methanesulfonate | 6190-39-2 | CH4O3S*C33H37N5O5 |
|
—— | Cinnarazine | 298-57-7 | C26H28N2 |
|
—— | 2-(diethylamino)ethyl (2S)-2-(naphthalen-1-ylmethyl)-3-[(2R)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | 2-(diethylamino)ethyl (2R)-2-(naphthalen-1-ylmethyl)-3-[(2R)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | 2-(diethylamino)ethyl (2R)-2-(naphthalen-1-ylmethyl)-3-[(2S)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | 2-(diethylamino)ethyl (2S)-2-(naphthalen-1-ylmethyl)-3-[(2S)-oxolan-2-yl]propanoate;oxalic acid | 3200-06-4 | C2H2O4*C24H33NO3 |
|
—— | Betahistine dihydrochloride | 5579-84-0 | C8H12N2*2ClH |
|
—— | vinpocetine | 42971-09-5 | C22H24N2O2 |
|
—— | Nicergolin | 27848-84-6 | C24H26BrN3O3 |
|
—— | (+/-)-alloerythro-1-(4-Hydroxy-phenyl)-2-<(4-phenyl-butyl-(2)-amino>-propanol-(1) | 447-41-6 | C19H25NO2 |
|
—— | (1<i>RS</i>,2<i>SR</i>)-1-(4-hydroxy-phenyl)-2-((<i>SR</i>)-1-methyl-3-phenyl-propylamino)-propan-1-ol | 447-41-6 | C19H25NO2 |
|
—— | (1<i>RS</i>,2<i>SR</i>)-1-(4-hydroxy-phenyl)-2-((<i>RS</i>)-1-methyl-3-phenyl-propylamino)-propan-1-ol | 447-41-6 | C19H25NO2 |
|
—— | Dilatol | 447-41-6 | C19H25NO2 |
|
—— | carvedilol oxalate | 72956-09-3 | C2H2O4*C24H26N2O4 |
|
—— | inositol hexanicotinate | 6556-11-2 | C42H30N6O12 |
|
—— | [(1S,5S)-3,3,5-trimethylcyclohexyl] (2R)-2-hydroxy-2-phenylacetate | 456-59-7 | C17H24O3 |
|